NQ [NQ Mobile] 8-A12B: (Original Filing)
[TABLE OF CONTENTS INFORMATION REQUIRED IN REGISTRATION STATEMENT INFORMATION REQUIRED IN REGISTRATION STATEMENT]
[TABLE OF CONTENTS INFORMATION REQUIRED IN REGISTRATION STATEMENT INFORMATION REQUIRED IN REGISTRATION STATEMENT]
[TABLE OF CONTENTS INFORMATION REQUIRED IN REGISTRATION STATEMENT INFORMATION REQUIRED IN REGISTRATION STATEMENT]
[] [Wholly-Owned Subsidiaries 1. Top Energy International Limited, a Hong Kong company 2. Changzhou Trina Solar Energy Co., Ltd., a PRC company 3. Trina Solar Korea Limited, a South Korean company 4. Trina Solar (Singapore) Pte. Ltd., a Singapore company 5. Trina Solar (Hong Kong) Enterprise Limited, a Hong Kong company 6. Trina Solar (Luxembourg) Holdings S.à.r.l, a Luxembourg company 7.] [CERTIFICATIONS I, Jifan Gao, certify that: 1. I have reviewed this annual report on Form 20-F of Trina Solar Limited. (the Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Terry Wang, certify that: 1. I have reviewed this annual report on Form 20-F of Trina Solar Limited (the Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jifan Gao Chairman and Chief Executive Officer] [CERTIFICATIONS (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Terry Wang Chief Financial Officer] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-160826 on Form F-3 and Nos. 333-144445 and 333-157831 on Form S-8 of our reports dated April 18, 2011, relating to the financial statements and financial statement schedule of Trina Solar Limited, and the effectiveness of Trina Solar Limiteds internal control over]
[] [Wholly-Owned Subsidiaries 1. Top Energy International Limited, a Hong Kong company 2. Changzhou Trina Solar Energy Co., Ltd., a PRC company 3. Trina Solar Korea Limited, a South Korean company 4. Trina Solar (Singapore) Pte. Ltd., a Singapore company 5. Trina Solar (Hong Kong) Enterprise Limited, a Hong Kong company 6. Trina Solar (Luxembourg) Holdings S.à.r.l, a Luxembourg company 7.] [CERTIFICATIONS I, Jifan Gao, certify that: 1. I have reviewed this annual report on Form 20-F of Trina Solar Limited. (the Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS I, Terry Wang, certify that: 1. I have reviewed this annual report on Form 20-F of Trina Solar Limited (the Company); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATIONS (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jifan Gao Chairman and Chief Executive Officer] [CERTIFICATIONS (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Terry Wang Chief Financial Officer] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No. 333-160826 on Form F-3 and Nos. 333-144445 and 333-157831 on Form S-8 of our reports dated April 18, 2011, relating to the financial statements and financial statement schedule of Trina Solar Limited, and the effectiveness of Trina Solar Limiteds internal control over]
[Copy of correspondence to: Stuart Management Company 33 Riverside Avenue th 5 Westport, CT 06880 x ¨ Form 20-F ¨ ¨ ¨ x Yes 1 Other Events. Company China Ceramics Co., Ltd. (the “ · On April 13, 2011, Paul Kelly purchased 20,000 of the Company’s shares for an aggregate purchase price of $89,020. · On April 13, 2011, William]
[Copy of correspondence to: Stuart Management Company 33 Riverside Avenue th 5 Westport, CT 06880 x ¨ Form 20-F ¨ ¨ ¨ x Yes 1 Other Events. Company China Ceramics Co., Ltd. (the “ · On April 13, 2011, Paul Kelly purchased 20,000 of the Company’s shares for an aggregate purchase price of $89,020. · On April 13, 2011, William]
[Sinovac Biotech Files Clinical Trial Applications with SFDA for its Proprietary Pneumococcal Polysaccharides Vaccines (PPV) -Completes Pre-Clinical Studies- Source: Sinovac Biotech Ltd. On Monday January 31, 2011, 8:00 am EST BEIJING, Jan. 31, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today the submission of the applications to commence human] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD.]
[Sinovac Biotech Files Clinical Trial Applications with SFDA for its Proprietary Pneumococcal Polysaccharides Vaccines (PPV) -Completes Pre-Clinical Studies- Source: Sinovac Biotech Ltd. On Monday January 31, 2011, 8:00 am EST BEIJING, Jan. 31, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today the submission of the applications to commence human] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD.]
[Sinovac Biotech Submits Clinical Trial Application to SFDA for Pneumococcal Conjugate Vaccine (PCV) -Completes Pre-Clinical Studies- Source: Sinovac Biotech Ltd. On Thursday March 3, 2011, 8:00 am EST BEIJING, March 3, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today it submitted the application to commence clinical trials for its] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD.]
[Sinovac Biotech Submits Clinical Trial Application to SFDA for Pneumococcal Conjugate Vaccine (PCV) -Completes Pre-Clinical Studies- Source: Sinovac Biotech Ltd. On Thursday March 3, 2011, 8:00 am EST BEIJING, March 3, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today it submitted the application to commence clinical trials for its] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD.]